Trial intelligence / Profile preview

Atorvastatin loading before primary PCI in STEMI

ChiCTR-TRC-11001221Phase 4Completed

Sponsor
The Second Affiliated Hospital of Nanchang University
Start
Dec 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of atorvastatin in myocardial infarction (MI) and acute ST-segment elevation myocardial infarction (STEMI) (2 arms), sponsored by The Second Affiliated Hospital of Nanchang University. Primary endpoint: Cardiovascular events. Started Dec 2010; status: completed.

02

Drugs

atorvastatin
03

Conditions

myocardial infarction (MI)acute ST-segment elevation myocardial infarction (STEMI)

Beyond the preview

Go deeper on ChiCTR-TRC-11001221.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-11001221.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call